U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Read also:

• What everyday objects become surprisingly challenging to use in zero gravity?
• CNN Gets A Big Viewership Bump With Live Telecast Of ‘Good Night, And Good Luck’ - Deadline
• What Gemini app features are free versus paid? [June 2025] - 9to5Google
• Newspaper headlines: 'A generation let down' and 'Israel claims control' - BBC
• What are the best AI tools for recruiting?
• I am upper middle class and study at the London School of economics and Finance (economics and Finance). I am 18 years old. What are my chances of becoming a billionaire?
• How is a narcissist likely to handle situations when confronted with hard truths about themselves?
• What are reasons you couldn't be a kpop idol?
• Jared Leto Accused of Sexual Misconduct by Multiple Women, Denies Allegations - People.com
• What were the first few days, weeks, months and then years like after finding out about your spouses infidelity? How did your feelings, and yours & their approach to the situation change in the immediate aftermath compared to later down the line?